<div class="container">

<table style="width: 100%;"><tr>
<td>PBC</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Primary biliary cirrhosis data</h2>

<h3>Description</h3>

<p>Primary biliary cirrhosis (PBC) data. PBC is a chronic liver disease which affects the bile 
ducts of the liver, complications of which can ultimately lead to death. The longitudinal 
profile of numerous biomarkers were observed for 312 patients at the Mayo Clinic between 1974
and 1984  with patients assigned to either the active (D-penicillamine, n=154 (50.6
placebo treatment arm (Murtaugh 1994). The data is publicly available in numerous places, 
including <code>joineRML</code> and <code>survival</code>. The presence of many longitudinal biomarkers 
of clinical interest as well as an event-time has lead to the PBC data becoming
widely used in literature.
</p>


<h3>Usage</h3>

<pre><code class="language-R">data('PBC')
</code></pre>


<h3>Format</h3>

<p><code>data.frame</code> with 312 patients and 19 variables:
</p>

<dl>
<dt><code>id</code></dt>
<dd>
<p>Subject identifier</p>
</dd>
<dt><code>survtime</code></dt>
<dd>
<p>Survival time in years</p>
</dd>
<dt><code>drug</code></dt>
<dd>
<p>Binary indicator covariate: was the patient assigned active 
(<code>drug=1</code>) or placebo?</p>
</dd>
<dt><code>sex</code></dt>
<dd>
<p>Binary indicator covariate: Takes value 1 if the subject is female, and zero
if male.</p>
</dd>
<dt><code>time</code></dt>
<dd>
<p>Time of visit (0=baseline).</p>
</dd>
<dt><code>ascites</code></dt>
<dd>
<p>Binary <em>response</em> variable. Takes value 1 if accumulation of fluid 
in abdomen ("ascites") present.</p>
</dd>
<dt><code>hepatomegaly</code></dt>
<dd>
<p>Binary <em>response</em> variable. Takes value 1 if enlarged liver 
("hepatomegaly") present.</p>
</dd>
<dt><code>spiders</code></dt>
<dd>
<p>Binary <em>response</em> variable. Takes value 1 if malformed blood 
vessels in skin ("hepatomegaly") present.</p>
</dd>
<dt><code>edema</code></dt>
<dd>
<p>Factor variable describing edema therapy, see 
<code>pbcseq</code>.</p>
</dd>
<dt><code>serBilir</code></dt>
<dd>
<p>Serum bilirubin (measured in mg/dl).</p>
</dd>
<dt><code>serChol</code></dt>
<dd>
<p>Serum cholesterol (measured in mg/dl).</p>
</dd>
<dt><code>album</code></dt>
<dd>
<p>Serum albumin (measured in mg/dl).</p>
</dd>
<dt><code>alkaline</code></dt>
<dd>
<p>Alkaline phosphotase (measured in U/liter).</p>
</dd>
<dt><code>SGOT</code></dt>
<dd>
<p>Aspartate aminotransferase (measured in U/liter).</p>
</dd>
<dt><code>platelets</code></dt>
<dd>
<p>Platelet count per cubic ml/1000.</p>
</dd>
<dt><code>histologic</code></dt>
<dd>
<p>Histologic stage of disease, see <code>pbcseq</code>.</p>
</dd>
<dt><code>status</code></dt>
<dd>
<p>Survival status, <code>status=1</code> if the subject experienced mortality 
and <code>=0</code> if censored.</p>
</dd>
<dt><code>age</code></dt>
<dd>
<p>Standardised age at baseline visit.</p>
</dd>
</dl>
<h3>Details</h3>

<p>Nine longitudinal biomarkers exist with varying degrees of completeness in the data.
</p>


<h3>Source</h3>

<p><code>pbcseq</code>
</p>


<h3>References</h3>

<p>Murtaugh PA, Dickson ER, Van Dam GM, Malinchoc M, Grambsch PM, Langworthy AL, Gips CH. Primary 
biliary cirrhosis: Prediction of short-term survival based on repeated patient visits. 
<em>Hepatology</em> 1994; <strong>20(1)</strong>; 126-134.
</p>


</div>